Showing results (41-50 of 173) with videos related to
Sort By:
Pageof 18
Journal of Clinical Medicine|August 26, 2023
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA SurveyMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.Cancers|August 26, 2023
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)Elisabetta Abruzzese, Monica Bocchia, Malgorzata Monika Trawinska, et al.Journal of Clinical Medicine|April 12, 2022
Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental TransferElisabetta Abruzzese, Stefano Aureli, Francesco Bondanini, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 13, 2024
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages eraAlessandra Vergori, Alessandro Cozzi Lepri, Marta Chiuchiarelli, et al.Journal of Hematology & Oncology|July 31, 2016
Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patientsGiovanni Caocci, Marianna Greco, Giuseppe Delogu, et al.Frontiers in Oncology|May 8, 2023
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's diseaseMariavita Ciccarone, Paola Cavaceppi, Cristiano Tesei, et al.Frontiers in Oncology|December 4, 2025
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologistsMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.Journal of Hematology & Oncology|December 6, 2019
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paperSimona Soverini, Elisabetta Abruzzese, Monica Bocchia, et al.Oncotarget|August 17, 2016
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patientsMonica Bocchia, Sara Galimberti, Lara Aprile, et al.Experimental Hematology|August 27, 2015
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patientsGiovanni Caocci, Bruno Martino, Marianna Greco, et al.Pageof 18